Fingerprint
Dive into the research topics of 'A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nitin Jain, Kumudha Balakrishnan, Alessandra Ferrajoli, Susan M. O'Brien, Jan A. Burger, Tapan M. Kadia, Jorge E. Cortes, Mary L. Ayres, Francesco Paolo Tambaro, Michael J. Keating, Varsha Gandhi, William G. Wierda
Research output: Contribution to journal › Article › peer-review